On Friday, November 2, 2018, a settlement was reached in Massachusetts federal court between Stryker Corp. and leadership counsel on behalf of plaintiffs seeking restitution from the company’s LIFT V40 hip implant component. The settlement—terms of which are confidential—resolves claims from certain lawsuits filed against the medical device company alleging that its femoral head component contributed …. Read More
Metal-on-metal hip implants manufactured by Stryker Orthopedics have been the subject of safety alerts and recalls in the past several years. Since the company’s August 2016 notification concerning its LFIT V40 femoral head, indicating a higher-than-expected number of complaints concerning the device, Stryker has expanded its safety notification to include eight additional products that include …. Read More
The bellwether selection process in the Stryker LFIT V40 artificial hip litigation has been formally outlined, according to a December 8, 2017 order from the Massachusetts court. A total of 18 cases, similarly alleging problems with Styker’s LFIT V40 femoral head—a component used in several hip replacement systems—will be selected for inclusion in the bellwether discovery …. Read More
Another complaint has been filed against Stryker Orthopedics concerning its hip replacement components, the LFIT V40 Femoral Head and Accolade TMFZ Hip Stem. Filed in Alabama district court, the plaintiff alleges the medical device manufacturer sold defective hip implant parts that were prone to corrosion, leading to severe pain, blood poisoning and revision surgery. In …. Read More
After thousands of Stryker Rejuvenate and ABG II metal-on-metal hip implants were recalled from the market in 2012 due to alarming failure rates and metallosis side effects, many recipients of the implant were required to undergo painful revision surgery to replace their defective hips. Over 5,000 patients sought litigation under a centralized multi-district litigation (MDL) …. Read More
